| May'19 | May'18 | May'17 | May'16 | May'15 | May'14 | May'13 | May'12 | May'11 | May'10 |
|---|---|---|---|---|---|---|---|---|---|
Product sales | |||||||||
- | - | - | - | - | - | - | - | - | 8,934 |
Cancellation charges | |||||||||
- | - | - | - | - | - | - | - | - | 2,740 |
Net sales | |||||||||
21,056 | 29,555 | 18,898 | 14,501 | 10,018 | 19,684 | 16,488 | 15,521 | 13,737 | 11,674 |
Cost of sales | |||||||||
13,454 | 17,169 | 12,118 | 9,356 | 6,180 | 9,462 | 9,712 | 9,314 | 8,225 | 5,571 |
Gross profit | |||||||||
7,602 | 12,386 | 6,780 | 5,145 | 3,838 | 10,222 | 6,776 | 6,207 | 5,512 | 6,103 |
Operating expenses: | |||||||||
Selling, general and administrative | |||||||||
7,724 | 7,290 | 7,052 | 6,975 | 6,470 | 6,323 | 6,872 | 6,526 | 5,964 | 6,094 |
Research and development | |||||||||
4,153 | 4,181 | 4,657 | 4,324 | 4,062 | 3,402 | 3,211 | 4,188 | 4,567 | 4,758 |
Restructuring | |||||||||
725 | 0 | 0 | - | - | - | - | - | - | - |
Gain on bankruptcy claim | |||||||||
- | - | - | - | - | - | - | - | 832 | - |
Gain on bankruptcy claim | |||||||||
- | - | - | - | - | - | - | - | - | -3,993 |
Total operating expenses | |||||||||
12,602 | 11,471 | 11,709 | 11,299 | 10,532 | 9,725 | 10,083 | 10,714 | 9,699 | 6,859 |
Income (loss) from operations | |||||||||
-5,000 | 915 | -4,929 | -6,154 | -6,694 | 497 | -3,307 | -4,507 | -4,187 | -756 |
Interest income | |||||||||
- | - | - | - | - | - | - | - | 3 | 5 |
Interest income (expense), net | |||||||||
252 | 399 | 678 | 605 | 130 | 26 | 49 | 4 | 0 | 0 |
Gain on sale of long-term investment | |||||||||
- | - | - | - | - | - | - | 990 | 0 | 0 |
Other (expense) income, net | |||||||||
44 | -61 | -21 | -16 | 211 | -64 | -33 | 117 | 762 | 131 |
Income (loss) before tax (expense) benefit | |||||||||
-5,208 | 455 | -5,628 | -6,775 | -6,613 | 407 | -3,389 | -3,404 | -3,422 | -620 |
Income tax (expense) benefit | |||||||||
27 | -73 | 25 | 10 | 34 | -15 | 30 | -15 | -49 | -139 |
Net income (loss) | |||||||||
-5,235 | 528 | -5,653 | -6,785 | -6,647 | 422 | -3,419 | -3,389 | -3,373 | - |
Less: Net income attributable to the noncontrolling interest | |||||||||
0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -16 | - |
Net income (loss) attributable to Aehr Test Systems common shareholders | |||||||||
-5,235 | 528 | -5,653 | -6,785 | -6,647 | 422 | -3,419 | -3,390 | -3,389 | -481 |
Net loss per share: Basic and Diluted | |||||||||
-0.23 | 0.02 | -0.35 | -0.52 | -0.55 | 0.04 | -0.36 | -0.38 | -0.39 | - |
Shares used in per share calculations: Basic and Diluted | |||||||||
- | - | - | - | - | - | - | - | 8 | - |
Net income (loss) per share basic | |||||||||
- | - | - | - | - | - | - | - | - | -0.06 |
Net income (loss) per share diluted | |||||||||
- | - | - | - | - | - | - | - | - | -0.06 |
Shares used in per share calculations: basic (in thousands) | |||||||||
22 | 21 | 16 | 13,091 | 12,047 | 10 | 9,549 | 9 | - | 8,563 |
Shares used in per share calculations: diluted (in thousands) | |||||||||
22 | 22 | 16 | 13,091 | 12,047 | 11 | 9,549 | 9 | - | 8,563 |